Preclinical Testing Shows Breezy aHP Activity Against Candida auris
Candida auris (C. auris) is an emerging multidrug-resistant fungus that is a growing concern for...
Stay up-to-date on Breezy Med and infection prevention automation with our press releases, blog articles, and case studies.
Candida auris (C. auris) is an emerging multidrug-resistant fungus that is a growing concern for...
Breezy Med is pleased to share the publication of a new peer-reviewed article in the Journal of...
Breezy Med is entering an exciting new chapter. Our automated aerosolized hydrogen peroxide (aHP)...
This year’s flu season is proving to be one of the most challenging in over a decade. Hospitals...
A recent Becker’s Hospital Review report revealed that measles cases are climbing across the United...
Infection prevention is one of the greatest challenges in long-term acute care hospitals. With...
The annual dread of the cold and flu season is upon us. As we brace for the coughs, sneezes, and...
Carbapenem-resistant organisms (CROs) are among the most urgent threats...
At Breezy Med, we believe infection prevention should be both effective and measurable. To support...
We’re excited to welcome Mike Johnson as Breezy Med’s new Senior Sales Representative, serving ...
Breezy Med is proud to introduce Breezy HaloSpray™, our most advanced disinfectant for hospital...
We're excited to announce that Breezy Med will be exhibiting at APIC25, the premier event for...